Keyphrases
Area under the Curve
16%
Clinical Outcomes
16%
Cmax
16%
Culture Conversion
16%
Diabetes Mellitus Patients
16%
Dose Limits
16%
Drug Concentration
16%
Drug Resistance
16%
Ethambutol
33%
High Dose
16%
Maximum Permissible Concentration
50%
Meta-analysis
33%
No Significant Difference
16%
Patients with Diabetes
16%
Patients with Diabetes Mellitus
50%
Pharmacokinetics
100%
Plasma Concentration
33%
Poor Clinical Outcomes
16%
Prospero
16%
Pyrazinamide
50%
Rifampicin
66%
Second-line Anti-tuberculosis Drugs
16%
Systematic Meta-analysis
16%
TB Drugs
100%
Treatment Failure
16%
Type 1 Diabetes Mellitus (T1DM)
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Dose Limit
11%
Drug Concentration
11%
Drug Resistance
11%
Ethambutol
22%
Isoniazid
33%
Pharmacokinetics
100%
Pyrazinamide
33%
Rifampicin
44%
Immunology and Microbiology
Blood Level
50%
Body Weight
25%
Drug Concentration
25%
Drug Megadose
25%
Drug Resistance
25%
Maximum Concentration
25%
Pharmacokinetics
100%